Véronique Bougie

Véronique Bougie holds the position of Chief Operating Officer at SemaThera Inc since July 2017, and serves as Chief Executive Officer of Anasens and Advisor at Aplantex, both roles initiated in late 2023. Bougie is also a board member for BIOQuébec and Montréal InVivo, contributing expertise to these organizations since 2020 and 2021, respectively. Previous experience includes consulting roles at Corbin Therapeutics Inc and MyX Therapeutics, alongside leadership as Chief Operating Officer and Acting Chief Executive Officer. Bougie's background in business development was honed at Gestion Univalor, where strategic project leadership was emphasized. Academic credentials include a Ph.D. candidature and a Master’s degree in Virology and Immunology, complemented by certifications in pharmaceutical product development and biopharma innovation from notable institutions such as the University of Oxford and Rutgers Business School.